Central effects of Ang-(1-7)/MasR
Ang-(1-7) induced effect | References |
---|---|
Decrease in blood pressure mediated by NO | Feng et al., 2010 [105] |
Decrease in NE release | Gironacci et al., 2004 [99] |
Decrease in NE synthesis | Lopez Verrilli et al., 2009[78] |
NE transporter upregulation | Lopez Verrilli et al., 2012[79] |
Angiogenesis | Goldstein et al., 2016 [106] |
Decrease in BBB permeability | Wu et al., 2015 [107] |
Protection of neurons and oligodendrocytes | Rabie et al., 2018 [108] |
Decrease in infarct size | Mecca et al., 2011 [109] |
Improvement in neurological deficits induced by stroke | Jiang et al., 2013 [28] |
Promotion of cell survival and healthy synapse formation | Costa-Besada et al., 2018 [66] |
Decrease in superoxide production in nucleus and mitochondria of neurons of the substancia nigra | Costa-Besada et al., 2018 [66] |
Increase in vasopressin release | Qadri et al., 1998 [110] |
Increase of BDNF production | Rabie et al., 2018 [108] |
Increased neuronal survival due to reduction of oxidative stress mediated by PKA | Mo et al., 2019 [111] |
Reduction in microglial activation and astrogliosis | Janatpour et al., 2019 [112] |
Reduction in inflammation by inhibition of the MAPKs pathway | Moore et al., 2013 [113] |
Increase of the M2 microglial anti-inflammatory phenotype in microglia | Liu et al, 2016 [114] |
NOS upregulation | Cerrato et al., 2012 [82] |
Reduction in oxidative stress | Jiang et al., 2013 [28]Costa-Besada et al., 2018 [66] |
Stimulation of prostaglandin release in endothelial cells | Jaiswal et al., 1992 [115] |
Stimulation of neuronal activity in hypothalamus and medulla | Fontes et al.,1994 [116] |
Increased sensitivity to baroreflex | Campagnole-Santos et al., 1992 [117] |
Increased IL-10 and decreased TNFα and IL1β | Sriramula et al., 2011[86] |
Increase of arachidonic acid release | Cerniello et al., 2020 [36] |
MAPKs and PKB/Akt activation | Rabie et al., 2018 [108] |
BDNF: brain derived neurotrophic factor; IL: interleukin; MAPK: mitogen-activated protein kinase; MCP-1: Monocyte chemoattractant protein-1; NOS: nitric oxide synthase; PKB: protein kinase B; TNFα: Tumor necrosis factor alpha
NLRM wrote the first draft of the manuscript; AMP wrote sections of the manuscript; MMG conceived the idea, wrote sections of the manuscript and critically reviewed the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2021.